By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


VasoGenix Pharmaceuticals, Inc. 

8527 Bluejacket Street

Lenexa  Kansas  66214  U.S.A.
Phone: 913-888-4773 Fax: 913-888-6928


Company News
VasoGenix Pharmaceuticals, Inc. Elects Cleveland Clinic's James Young, M.D., to its Board of Directors 5/19/2009 11:48:32 AM
VasoGenix Pharmaceuticals, Inc. Elects Pharma Industry Veteran Dr. Judith A. Hemberger to Its Board of Directors 3/23/2009 1:11:46 PM
VasoGenix Pharmaceuticals, Inc. Selects A Lead CGRP(Calcitonin Gene-Related Peptide) Agonist Analog To Develop As A Heart Failure 2/11/2009 1:44:36 PM
VasoGenix Pharmaceuticals, Inc. Elects Former AVAX Technologies, Inc. (AVXT) CEO Richard P. Rainey to Its Board of Directors 2/3/2009 11:24:37 AM
VasoGenix Pharmaceuticals, Inc. Awarded $400,000 by Kansas Bioscience Authority to Continue Development of its CGRP (Calcitonin Gene-Related Peptide) Analogs for Treating Heart Failure 1/29/2009 10:47:49 AM
VasoGenix Pharmaceuticals, Inc. Reports that Preclinical Testing of CGRP (Calcitonin Gene-Related Peptide) Analogs May Be Useful in Treating Heart Failure 10/27/2008 9:56:52 AM
VasoGenix Pharmaceuticals, Inc. Presents Data Related to CGRP (Calcitonin Gene Related Peptide) for Heart Failure Patients 11/26/2007 10:23:17 AM
VasoGenix Pharmaceuticals, Inc. Elects Jerome A. Halperin, Former President And CEO Of The Food & Drug Law Institute, To The Company's Board Of Directors 6/13/2006 12:26:47 PM
VasoGenix Pharmaceuticals, Inc. And Cleveland Clinic Sign Phase I/II Safety And Efficacy Clinical Trial Agreement To Develop CGRP (Calcitonin Gene Related Peptide) For Heart Failure Patients 5/15/2006 12:22:29 PM
VasoGenix Pharmaceuticals, Inc. To Present At Medtech Insight And Windhover Information Inc.'s "In3 Medical Device Summit'' Conference, June 21-23, 2006 In San Francisco, California 5/11/2006 12:14:22 PM